195 related articles for article (PubMed ID: 37359405)
1. How can we deliver on the promise of precision medicine in oncology and beyond? A practical roadmap for action.
Baird AM; Westphalen CB; Blum S; Nafria B; Knott T; Sargeant I; Harnik H; Brooke N; Wicki N; Wong-Rieger D
Health Sci Rep; 2023 Jun; 6(6):e1349. PubMed ID: 37359405
[TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
3. Stakeholders' expectations of precision medicine: A qualitative study to identify areas of (mis)alignment.
Knott T; Creeden J; Horbach B; Rauch-Zumbrägel M; Vat L; Harnik H; Maravic Z
Health Sci Rep; 2023 Aug; 6(8):e1428. PubMed ID: 37599652
[TBL] [Abstract][Full Text] [Related]
4. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.
Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P
JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528
[TBL] [Abstract][Full Text] [Related]
5. The Roadmap toward Personalized Medicine: Challenges and Opportunities.
Cinti C; Trivella MG; Joulie M; Ayoub H; Frenzel M;
J Pers Med; 2024 May; 14(6):. PubMed ID: 38929767
[TBL] [Abstract][Full Text] [Related]
6. THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar.
Qoronfleh MW; Chouchane L; Mifsud B; Al Emadi M; Ismail S
Life Sci Soc Policy; 2020 Nov; 16(1):12. PubMed ID: 33129349
[TBL] [Abstract][Full Text] [Related]
7. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
8. Impact of Clinical Practice Gaps on the Implementation of Personalized Medicine in Advanced Non-Small-Cell Lung Cancer.
Sadik H; Pritchard D; Keeling DM; Policht F; Riccelli P; Stone G; Finkel K; Schreier J; Munksted S
JCO Precis Oncol; 2022 Oct; 6():e2200246. PubMed ID: 36315914
[TBL] [Abstract][Full Text] [Related]
9. Implementation of precision medicine in healthcare-A European perspective.
Stenzinger A; Moltzen EK; Winkler E; Molnar-Gabor F; Malek N; Costescu A; Jensen BN; Nowak F; Pinto C; Ottersen OP; Schirmacher P; Nordborg J; Seufferlein T; Fröhling S; Edsjö A; Garcia-Foncillas J; Normanno N; Lundgren B; Friedman M; Bolanos N; Tatton-Brown K; Hill S; Rosenquist R
J Intern Med; 2023 Oct; 294(4):437-454. PubMed ID: 37455247
[TBL] [Abstract][Full Text] [Related]
10. The project data sphere initiative: accelerating cancer research by sharing data.
Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
[TBL] [Abstract][Full Text] [Related]
11. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
Newell S; Jordan Z
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
[TBL] [Abstract][Full Text] [Related]
12. An Assessment of the Knowledge and Perceptions of Precision Medicine (PM) in the Rwandan Healthcare Setting.
Musanabaganwa C; Ruton H; Ruhangaza D; Nsabimana N; Kayitare E; Muvunyi TZ; Semakula M; Ntirenganya F; Musoni E; Ndoli J; Hategekimana E; Nassir A; Makokha F; Uwimana A; Gasana J; Munezero PC; Uwinkindi F; Muvunyi CM; Nyirazinyoye L; Mazarati JB; Mutesa L
J Pers Med; 2023 Dec; 13(12):. PubMed ID: 38138934
[TBL] [Abstract][Full Text] [Related]
13. A survey of experts on personalized medicine landscape in European Union and China.
Hoxhaj I; Beccia F; Morsella A; Cadeddu C; Ricciardi W; Boccia S
BMC Health Serv Res; 2023 May; 23(1):517. PubMed ID: 37221524
[TBL] [Abstract][Full Text] [Related]
14. [The collaborative project "Personalized medicine for oncology" (PM4Onco) as part of the Medical Informatics Initiative (MII)].
Metzger P; Boerries M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2024 Jun; 67(6):668-675. PubMed ID: 38739266
[TBL] [Abstract][Full Text] [Related]
15. Stakeholders Perceptions of Barriers to Precision Medicine Adoption in the United States.
Schroll MM; Agarwal A; Foroughi O; Kong E; Perez O; Pritchard D; Breur T; Garner Amanti K; Gustavsen G
J Pers Med; 2022 Jun; 12(7):. PubMed ID: 35887521
[TBL] [Abstract][Full Text] [Related]
16. Evolving assessment pathways for precision oncology medicines to improve patient access: a tumor-agnostic lens.
Radu P; Kumar G; Cole A; Fameli A; Guthrie M; Annemans L; Geissler J; Italiano A; O'Rourke B; Xoxi E; Steuten L
Oncologist; 2024 Jun; 29(6):465-472. PubMed ID: 38630538
[TBL] [Abstract][Full Text] [Related]
17. From precision medicine to precision care: Choosing and using precision medicine in the context of multimorbidity.
Bierman AS; Burke BT; Comfort LN; Gerstein M; Mueller NM; Umscheid CA
Camb Prism Precis Med; 2023; 1():e19. PubMed ID: 38550931
[TBL] [Abstract][Full Text] [Related]
18. Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm.
Lajmi N; Alves-Vasconcelos S; Tsiachristas A; Haworth A; Woods K; Crichton C; Noble T; Salih H; Várnai KA; Branford-White H; Orrell L; Osman A; Bradley KM; Bonney L; McGowan DR; Davies J; Prime MS; Hassan AB
Camb Prism Precis Med; 2024; 2():e4. PubMed ID: 38699518
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
